Bioanalytical Systems, Inc. Announces Corporate Name Change to Inotiv, Inc.
March 19 2021 - 4:05PM
Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”,
“We”, “Our” or “Inotiv”), a leading provider of
nonclinical and analytical contract research services, today
announced a change of the Company’s corporate name from
Bioanalytical Systems, Inc. to Inotiv, Inc.
The name change was approved by the Company’s shareholders on
March 18, 2021, at the Company’s annual meeting of shareholders and
became effective as of the filing of articles of amendment to the
Company’s Second Amended and Restated Articles of Incorporation, as
amended, that same day. Effective Monday, March 22, 2021, The
Company’s common shares will trade under the ticker symbol “NOTV.”
The Company’s common shares have been assigned a new CUSIP number
of 45783Q 100. The corporate name change to Inotiv, Inc. does not
affect the rights of the Company’s shareholders or the number of
outstanding common shares and no action is required by shareholders
with respect to the name change, the ticker symbol change or the
CUSIP number change.
The corporate name change to Inotiv, Inc. reinforces the
Company’s contract research services brand originally launched in
November 2019, and represents the coming together of the Company’s
legacy contract research services with those acquired in the
Seventh Wave Laboratories, Smithers Avanza Toxicology Services, and
Pre-Clinical Research Services acquisitions. The unified Company
continues to provide top-tier in vivo toxicology, pharmacology,
drug metabolism, bioanalysis, pathology, pharmacokinetic, and
surgical and medical device discovery and development
solutions.
“Since the launch of the Inotiv brand in 2019, we’ve worked hard
to execute on our growth strategy by strengthening our
capabilities, investing in our service offerings, infrastructure
and people, and messaging our ‘Expect More’ philosophy to prospects
and clients,” said Company President and Chief Executive Officer
Robert Leasure, Jr. “Changing our corporate name was a logical step
towards solidifying our brand and clearly communicating what it
reflects— a broadly capable, right-sized CRO with a fundamental
goal of delivering exceptional client experiences.”
The Company intends to continue to operate its research product
manufacturing division under the name BASi Research Products.
About the Company
Inotiv, Inc. is a pharmaceutical development
company providing contract research services and monitoring
instruments to emerging pharmaceutical companies and the world's
leading drug development companies and medical research
organizations. The Company focuses on developing innovative
services supporting its clients’ discovery and development
objectives for improved decision-making and accelerated goal
attainment. The Company’s products focus on increasing efficiency,
improving data, and reducing the cost of taking new drugs to
market. Visit inotivco.com for more information about the
Company.
This release may contain forward-looking
statements that are subject to risks and uncertainties including,
but not limited to, risks and uncertainties related to changes in
the market and demand for our products and services, the
development, marketing and sales of products and services, changes
in technology, industry and regulatory standards, the timing of
acquisitions and the successful closing, integration and business
and financial impact thereof, the impact of the COVID-19 pandemic
on the economy, demand for our services and products and our
operations, including the measures taken by governmental
authorities to address the pandemic, which may precipitate or
exacerbate other risks and/or uncertainties and various other
market and operating risks, including those detailed in the
Company's filings with the U.S. Securities and Exchange
Commission.
Company Contact |
|
Investor Relations |
Inotiv, Inc. |
|
The Equity Group Inc. |
Beth A. Taylor, Chief Financial Officer |
|
Kalle Ahl, CFA |
(765) 497-8381 |
|
(212) 836-9614 |
btaylor@inotivco.com |
|
kahl@equityny.com |
|
|
|
|
|
Devin Sullivan |
|
|
(212) 836-9608 |
|
|
dsullivan@equityny.com |
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Apr 2023 to Apr 2024